Gene · 9376
Papers2,037
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 2,037
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Ab initio modeling and ligand docking of quercetin and the MC-LR transporter protein Oatp1b2/OATP1B3. | Pharm Sci Adv | 2023 | 41550783 | PubTator, text mining | PubMed |
| Case Report: Diabetic ketoacidosis after co-administration of empagliflozin and probenecid. | Wellcome Open Res | 2023 | 39114818 | PubTator, text mining | PubMed |
| Effect of Oregon grape root extracts on P-glycoprotein mediated transport in in vitro cell lines. | J Pharm Pharm Sci | 2023 | 38304488 | PubTator, text mining | PubMed |
| Development of a Highly Differentiated Human Primary Proximal Tubule MPS Model (aProximate MPS Flow). | Bioengineering (Basel) | 2023 | 38275575 | PubTator, text mining | PubMed |
| Neurosyphilis: insights into its pathogenesis, susceptibility, diagnosis, treatment, and prevention. | Front Neurol | 2023 | 38274871 | PubTator, text mining | PubMed |
| Association between genetic variants of membrane transporters and the risk of high-grade hematologic adverse events in a cohort of Mexican children with B-cell acute lymphoblastic leukemia. | Front Oncol | 2023 | 38269022 | PubTator, text mining | PubMed |
| Recent progress in metabolic reprogramming in gestational diabetes mellitus: a review. | Front Endocrinol (Lausanne) | 2023 | 38234430 | PubTator, text mining | PubMed |
| Editorial: Genetic disorders and rare diseases: in vitro models for preclinical pharmacological studies and translation. | Front Pharmacol | 2023 | 38186642 | PubTator, text mining | PubMed |
| Antiviral Activity of Probenecid and Oseltamivir on Influenza Virus Replication. | Viruses | 2023 | 38140606 | PubTator, text mining | PubMed |
| Cranberry Proanthocyanidins Mitigate Reflux-Induced Transporter Dysregulation in an Esophageal Adenocarcinoma Model. | Pharmaceuticals (Basel) | 2023 | 38139823 | PubTator, text mining | PubMed |
| Pharmacokinetics of Dacarbazine and Unesbulin and CYP1A2-Mediated Drug Interactions in Patients With Leiomyosarcoma. | Clin Transl Sci | 2023 | 38129988 | PubTator, text mining | PubMed |
| Precision nephrotoxicity testing using 3D in vitro models. | Cell Biosci | 2023 | 38129901 | PubTator, text mining | PubMed |
| Evaluation of the efficacy and safety of nirmatrelvir/ritonavir co-administration inpatients with rheumatic disease infected with SARS-CoV-2: a real-world study. | Front Pharmacol | 2023 | 38125894 | PubTator, text mining | PubMed |
| Antihypertensives associated adverse events: a review of mechanisms and pharmacogenomic biomarkers available evidence in multi-ethnic populations. | Front Pharmacol | 2023 | 38108069 | PubTator, text mining | PubMed |
| TCM and related active compounds in the treatment of gout: the regulation of signaling pathway and urate transporter. | Front Pharmacol | 2023 | 38094893 | PubTator, text mining | PubMed |
| Inhibitory effect of napabucasin on arbidol metabolism and its mechanism research. | Front Pharmacol | 2023 | 38094891 | PubTator, text mining | PubMed |
| DNDI-6174 is a preclinical candidate for visceral leishmaniasis that targets the cytochrome bc1. | Sci Transl Med | 2023 | 38091406 | PubTator, text mining | PubMed |
| Reduced blood glucose levels by the combination of vadadustat in an elderly patient with chronic kidney disease who was receiving mitiglinide and sitagliptin: a case report. | J Pharm Health Care Sci | 2023 | 38072987 | PubTator, text mining | PubMed |
| NEDD4L in human tumors: regulatory mechanisms and dual effects on anti-tumor and pro-tumor. | Front Pharmacol | 2023 | 38027016 | PubTator, text mining | PubMed |
| Albumin-bound kynurenic acid is an appropriate endogenous biomarker for assessment of the renal tubular OATs-MRP4 channel. | J Pharm Anal | 2023 | 38024860 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9376/papers?page=8